Sun Pharma Whole Time Director Sudhir Valia steps down from executive role
Earlier in January 2019, Sun Pharma had said that it had not given any loans nor guarantees to Suraksha Realty, a company in which Sudhir Valia is one of the promoters.
New Delhi: Sudhir Valia, brother-in-law of Sun Pharma's Managing Director Dilip Shanghvi, has stepped down from the position of the whole-time director but will continue as a non-executive director of the company, a regulatory filing said.
The pharma major in a filing on Tuesday said Valia will step down from the position of the company's whole-time director to non-executive, non-independent director from May 29, 2019.
Also Read: Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report
Asked for the reasons for Valia shifting to a non-executive role, a Sun Pharma spokesperson said, "As his personal businesses are increasingly taking more of his time, he has decided to give up the role of a whole-time director in the company."
Earlier in January 2019, Sun Pharma had said that it had not given any loans nor guarantees to Suraksha Realty, a company in which Valia is one of the promoters.
Sudhir Vrundavandas Valia served as Whole Time Director of Sun Pharmaceutical Industries Limited since February 11, 2005 and was responsible for finance, commercial, operations, projects and quality control.
He carries more than three decades of experience in taxation and finance. He served as the Chief Financial Officer of Sun Pharma Advanced Research Company Limited from July 31, 2014 to January 31, 2017. 62 years old Valia is connected to 22 board members in 6 different organisations across 7 different countries.
He is a Fellow Member of Institute of Chartered Accountants of India and carries more than two decades of Taxation and Finance experience. He is actively involved in the field of social activities and he was awarded the Adivasi Sevak Puraskar (2008 -2009) by the Government of Maharashtra for his contribution towards the welfare of tribals, particularly in the field of education in his capacity as visionary and Director of Shantilal Shanghvi Foundation.
He is a Qualified Chartered Accountant in India. Prior to December 1993, Valia was a Chartered Accountant in private practice. He holds a Bachelor’s degree in Commerce from the University of Mumbai.
Valia has won several awards including CNBC TV 18’s CFO of the Year in the Pharmaceutical and Healthcare Sectors for two consecutive years - 2011 and 2012, as well as in the year 2009.
Also Read: Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence
New Delhi: Sudhir Valia, brother-in-law of Sun Pharma's Managing Director Dilip Shanghvi, has stepped down from the position of the whole-time director but will continue as a non-executive director of the company, a regulatory filing said.
The pharma major in a filing on Tuesday said Valia will step down from the position of the company's whole-time director to non-executive, non-independent director from May 29, 2019.
Also Read: Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report
Asked for the reasons for Valia shifting to a non-executive role, a Sun Pharma spokesperson said, "As his personal businesses are increasingly taking more of his time, he has decided to give up the role of a whole-time director in the company."
Earlier in January 2019, Sun Pharma had said that it had not given any loans nor guarantees to Suraksha Realty, a company in which Valia is one of the promoters.
Sudhir Vrundavandas Valia served as Whole Time Director of Sun Pharmaceutical Industries Limited since February 11, 2005 and was responsible for finance, commercial, operations, projects and quality control.
He carries more than three decades of experience in taxation and finance. He served as the Chief Financial Officer of Sun Pharma Advanced Research Company Limited from July 31, 2014 to January 31, 2017. 62 years old Valia is connected to 22 board members in 6 different organisations across 7 different countries.
He is a Fellow Member of Institute of Chartered Accountants of India and carries more than two decades of Taxation and Finance experience. He is actively involved in the field of social activities and he was awarded the Adivasi Sevak Puraskar (2008 -2009) by the Government of Maharashtra for his contribution towards the welfare of tribals, particularly in the field of education in his capacity as visionary and Director of Shantilal Shanghvi Foundation.
He is a Qualified Chartered Accountant in India. Prior to December 1993, Valia was a Chartered Accountant in private practice. He holds a Bachelor’s degree in Commerce from the University of Mumbai.
Valia has won several awards including CNBC TV 18’s CFO of the Year in the Pharmaceutical and Healthcare Sectors for two consecutive years - 2011 and 2012, as well as in the year 2009.
Also Read: Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd